Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Feldmann

Showing results (421-430 of 568) with videos related to

Pageof 57
Sort By:
British Journal of Rheumatology|November 5, 1997
Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockadeD Davis, P J Charles, A Potter, et al.
Concepts in Immunopathology|January 1, 1988
Regulation of HLA class II expression and the pathogenesis of autoimmunityM Feldmann, M Londei, M Kissonerghis, et al.
Journal of Autoimmunity|December 1, 1990
Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseasesR Q Zheng, E R Abney, B Grubeck-Loebenstein, et al.
European Journal of Immunology|November 1, 1987
Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathwaysJ R Lamb, E D Zanders, W Sewell, et al.
Lancet (London, England)|February 11, 1989
CD4+ T-cell damage to islet beta cellsP De Berardinis, M Londei, R F James, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Human T-cell responses in vitro: cell interactions and factorsA Rees, M Feldmann, P Erb, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapyA M Yamamoto, Y Chernajovsky, F Lepault, et al.
Arthritis and Rheumatism|July 1, 1996
Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritisE M Paleolog, M Hunt, M J Elliott, et al.
Lancet (London, England)|October 8, 1988
Do CD4-positive cytotoxic T cells damage islet beta cells in type 1 diabetes?P de Berardinis, M Londei, R F James, et al.
Clinical and Experimental Rheumatology|July 1, 1990
CD5+B cells in rheumatoid arthritis and Sjögren's syndromeR N Maini, C Plater-Zyberk, C M Brown, et al.
Pageof 57

Showing results (421-430 of 568) with videos related to

Sort By:
Pageof 57
British Journal of Rheumatology|November 5, 1997
Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockadeD Davis, P J Charles, A Potter, et al.
Concepts in Immunopathology|January 1, 1988
Regulation of HLA class II expression and the pathogenesis of autoimmunityM Feldmann, M Londei, M Kissonerghis, et al.
Journal of Autoimmunity|December 1, 1990
Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves' and Hashimoto's diseasesR Q Zheng, E R Abney, B Grubeck-Loebenstein, et al.
European Journal of Immunology|November 1, 1987
Antigen-specific T cell unresponsiveness in cloned helper T cells mediated via the CD2 or CD3/Ti receptor pathwaysJ R Lamb, E D Zanders, W Sewell, et al.
Lancet (London, England)|February 11, 1989
CD4+ T-cell damage to islet beta cellsP De Berardinis, M Londei, R F James, et al.
Annals of the New York Academy of Sciences|January 1, 1979
Human T-cell responses in vitro: cell interactions and factorsA Rees, M Feldmann, P Erb, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 6, 2001
The activity of immunoregulatory T cells mediating active tolerance is potentiated in nonobese diabetic mice by an IL-4-based retroviral gene therapyA M Yamamoto, Y Chernajovsky, F Lepault, et al.
Arthritis and Rheumatism|July 1, 1996
Deactivation of vascular endothelium by monoclonal anti-tumor necrosis factor alpha antibody in rheumatoid arthritisE M Paleolog, M Hunt, M J Elliott, et al.
Lancet (London, England)|October 8, 1988
Do CD4-positive cytotoxic T cells damage islet beta cells in type 1 diabetes?P de Berardinis, M Londei, R F James, et al.
Clinical and Experimental Rheumatology|July 1, 1990
CD5+B cells in rheumatoid arthritis and Sjögren's syndromeR N Maini, C Plater-Zyberk, C M Brown, et al.
Pageof 57